CAP48 - Autism in Children and Adolescents (CAP48-ASD)

May 22, 2025 updated by: Université Catholique de Louvain

CAP48 Medical Research Project: Autism Spectrum Disorders in Children and Adolescents

Evaluation and follow-up of children diagnosed with an autism spectrum disorder in French-speaking Belgium in order to optimize diagnostic protocols, the quality of care required and its accessibility, and to determine the impact of an autism spectrum disorder on schooling, family and society.

Study Overview

Status

Recruiting

Intervention / Treatment

Detailed Description

The aims of the research project:

  • To collect a wide range of data in order to improve knowledge of children with autism spectrum disorder (ASD) in French-speaking Belgium by prospectively including all children and adolescents making a request to the centres of reference. The creation of a common database will make it possible to collect general socio-demographic, geographical and epidemiological data, to characterise the different profiles and to accurately monitor developmental trajectories.
  • Evaluate the feasibility and practical implementation of the treatment proposed following a diagnosis of ASD in a child.
  • Implement protocols to improve the quality of care for beneficiaries.
  • To enable the development of fundamental research protocols. Many questions remain unanswered about the genetic, neuro-cognitive and linguistic characteristics of autism. Only rigorous studies carried out on large, carefully defined samples can advance research.
  • Increase public knowledge and understanding of the ASD.

Study Type

Observational

Enrollment (Estimated)

500

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

children/adolescents (under 18 years of age) who apply to an autism reference center or who are followed up in an autism reference center.

Description

Inclusion Criteria:

  • children/adolescents (under 18 years of age) who apply to an autism reference center or who are followed up in an autism reference center from French-speaking region of Belgium.

Exclusion Criteria:

  • refusal by the family to allow their child's data to be included in the database.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
ASD group
child/adolescent (under 18 years of age) applying to an autism reference center or being followed up in an autism reference center
socio-demographic data collection and proposed therapy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Creation of an ADS register
Time Frame: Throughout the entire study, approximately during 5 years
creation of a common ASD register to collect general sociodemographic, geographic and epidemiological data, characterize the different patient profiles and accurately track development trajectories
Throughout the entire study, approximately during 5 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Feasability assessment
Time Frame: Throughout the entire study, approximately during 5 years
Evaluate the feasibility and practical realization of the proposed care following a diagnosis of ASD in a child and implement protocols to improve the quality of therapy.
Throughout the entire study, approximately during 5 years
Protocols development
Time Frame: Throughout the entire study, approximately during 5 years
Enable the development of fundamental research protocols: genetic, neurocognitive and linguistic
Throughout the entire study, approximately during 5 years
Schooling evaluation
Time Frame: Throughout the entire study, approximately during 5 years
Evaluate the schooling of children with ASD of all ages
Throughout the entire study, approximately during 5 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Marine Houssa, PhD, Université Catholique de Louvain

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 15, 2023

Primary Completion (Estimated)

December 31, 2028

Study Completion (Estimated)

December 31, 2028

Study Registration Dates

First Submitted

November 20, 2023

First Submitted That Met QC Criteria

November 20, 2023

First Posted (Actual)

November 29, 2023

Study Record Updates

Last Update Posted (Actual)

May 29, 2025

Last Update Submitted That Met QC Criteria

May 22, 2025

Last Verified

May 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Autism Spectrum Disorder

Clinical Trials on inclusion in the register

Subscribe